Sub-Picogram Level Quantitation of Desmopressin in Small Volumes of Human Plasma Using a Trap-Elute Microflow

Importance of the Topic

Desmopressin is a synthetic vasopressin analog widely used for managing conditions such as diabetes insipidus and nocturia. Therapeutic doses result in extremely low plasma concentrations, often at sub-picogram per milliliter levels. Accurate quantitation at these levels is critical for pharmacokinetic studies, bioanalysis, and quality control in pharmaceutical research.

Objectives and Study Overview

The study aimed to develop a highly sensitive microflow LC-MS/MS method to quantify desmopressin at 0.5 pg/mL in human plasma using significantly reduced sample volumes. By combining trap-elute microflow chromatography with a QTRAP® 6500+ system and OptiFlow™ Turbo V Source, the method sought to maintain low limits of quantitation while minimizing plasma consumption by over threefold.

Methodology and Instrumentation

Sample preparation employed weak cation exchange solid-phase extraction to isolate desmopressin from 300 µL plasma. Cartridges were conditioned, loaded with spiked plasma plus acid, washed, and eluted before drying and reconstitution in 0.1% acetic acid.

Chromatography utilized a trap-elute configuration:

• Trap column: Phenomenex Luna 5 µm C18, 20×0.3 mm at 40 µL/min with 0.1% acetic acid in water/acetonitrile.
• Analytical column: Phenomenex Kinetex 2.6 µm XB-C18, 50×0.3 mm at 5 µL/min, gradient from 90:10 to 5:95 water/acetonitrile with 0.1% acetic acid.

MS detection was achieved on the QTRAP 6500+ with OptiFlow Turbo V Source and a 25 µm SteadySpray™ electrode. Multiple reaction monitoring transitions for desmopressin and its D5 internal standard were optimized (e.g., m/z 535.4↔ 328.2). Source and gas parameters were tuned for low-flow operation.

Instrumentation Used

• SCIEX QTRAP 6500+ LC-MS/MS system
• OptiFlow Turbo V Source with SteadySpray electrode
• M5 MicroLC system in trap-elute mode
• ExionLC AD HPLC system (for analytical flow comparison)

Key Results and Discussion

The microflow method achieved a lower limit of quantitation of 0.5 pg/mL using only 300 µL of plasma. Calibration curves from 0.5 to 250 pg/mL demonstrated excellent linearity (r = 0.997) with accuracy between 91.8% and 104.3% and precision (CV) within FDA bioanalytical criteria. Matrix blanks showed no interference. Comparison with analytical flow (0.5 mL/min) confirmed a threefold sensitivity improvement, allowing reduced sample consumption.

Benefits and Practical Applications

The developed microflow LC-MS/MS method offers:

• High sensitivity for sub-picogram peptide quantitation
• Reduced plasma volume requirements
• Robust and reproducible performance
• Minimal source optimization and rapid throughput

These advantages support its use in pharmacokinetic, toxicokinetic, and clinical peptide bioanalysis.

Future Trends and Potential Applications

Emerging directions include further miniaturization to nanoflow regimes, integration with automated on-line SPE, and multiplexed analyses for panels of therapeutic peptides or biomarkers. Advances in microfluidic interfaces and high-resolution mass spectrometry will expand applications in clinical research and personalized medicine.

Conclusion

A trap-elute microflow LC-MS/MS approach using the QTRAP 6500+ system with OptiFlow Turbo V Source and M5 MicroLC achieved reliable, high-sensitivity quantitation of desmopressin at 0.5 pg/mL with significantly lower plasma consumption. This method advances peptide bioanalysis by combining throughput, robustness, and trace-level detection.

References

1. Gudlawar SK, Pilli NR, Siddiraju S, Dwivedi J. Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC–MS/MS. Journal of Pharmaceutical Analysis. 2017;7(3):196–202.
2. Baghla R, Guttikar S, et al. A Sub-picogram quantification method for desmopressin in plasma using the SCIEX Triple Quad 6500 System. SCIEX Technical Note. RUO-MKT-02-8508-A; 2018.